Abstract

Paget’s disease of bone (PDB) is characterised by increased but disorganised bone remodelling, leading to various complications including pain, deformity, and fracture. It is a relatively uncommon condition but important to recognise as it is a potentially treatable cause of bone pain. This article provides guidance to primary care teams on the diagnosis and management of patients with PDB based on a recent clinical guideline.1 PDB is caused by increased osteoclast activity that is coupled with increased, but disorganised, bone formation, causing the affected bones to become deformed and more susceptible to fracture. Paget’s disease is rare below the age of 50 but becomes progressively more common thereafter and males are affected more often than females (1.4:1).2 Paget’s disease has a strong genetic component and particularly targets people of British descent.2 In some families, it is inherited as an autosomal dominant trait, most commonly because of mutations in the SQSTM1 gene whereas, in others, there is familial clustering with no clear pattern of inheritance.3 Emerging evidence indicates that susceptibility to PDB is accounted for, in part, by inheritance of variants in genes that cause upregulation of osteoclast activity. Environmental …

Highlights

  • C Nairn, MB ChB, GP trainee, St Triduana’s Medical Practice, Edinburgh

  • Teams on the diagnosis and management of The most common presentation is with patients with Paget’s disease of bone (PDB) based on a recent clinical bone pain but PDB can present with guideline.[1] bone deformity, deafness, or pathological

  • Paget’s disease with osteosarcoma (0.3% of patients), which is rare below the age of 50 but becomes usually presents with a local increase in progressively more common thereafter swelling and pain at an affected site

Read more

Summary

Catherine Nairn and Stuart H Ralston

C Nairn, MB ChB, GP trainee, St Triduana’s Medical Practice, Edinburgh. SH Ralston, MD, FRCP, FRSE, professor of rheumatology, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh.

Address for correspondence
INTRODUCTION
PATIENT SUSPECTED OF HAVING PDB?
Findings
WHEN SHOULD PATIENTS BE REFERRED TO SECONDARY CARE?
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call